Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

HISTORICAL FACTS: Verv | History Defined

3 Bullish Biotech Stocks With Explosive Growth Trends

These small-cap biotech stocks offer high-reward potential with bullish momentum and key catalysts ahead in urology, autoimmune, and gene editing therapies

MarketBeat · Jul 21, 2025

3 Small-Cap Healthcare Stocks With Big Upside Potential

Small-cap healthcare stocks offer a unique opportunity for investors looking to capitalize on innovation and high growth. Thus, investors might consider keeping an eye on three small-cap healthcare stocks, Verve Therapeutics (VERV), Immatics N.V. (IMTX), and Esperion Therapeutics (ESPR), that offer big upside potential. Read on….

StockNews.com · Jan 9, 2025

3 Stocks to Sell Ahead of a Potential Recession in 2023

Fears of an impending recession have been a drag on the stock market for quite a while now. As the Fed continues to stay hawkish, a global recession seems imminent. Hence, fundamentally weak stocks Verve Therapeutics (VERV), Bed Bath & Beyond (BBBY), and Party City Holdco (PRTY) might be best…

StockNews.com · Jan 17, 2023

From analysis to the latest developments in health,
read the most diverse news in one place.

Dow Jumps Over 200 Points; Verve Therapeutics Shares Plummet

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Monday.

Benzinga · Nov 7, 2022

2 Cathie Wood Stocks It Would Be Wise to Avoid

With the Fed seemingly yet to be done with aggressive rate hikes to control sky-high inflation, troubles for Cathie Wood’s fleet of ETFs seem far from over. Due to overexposure to disruptive, tech-oriented businesses and cash-guzzling businesses, her investments' near-term outlook appears bleak. Hence, fundamentally weak Cathie Wood holdings Ui…

StockNews.com · Oct 25, 2022

4 Cathie Wood Stocks to Sell Now

Cathie Wood’s ETFs performed miserably this year amid a market rout caused by soaring inflation, the Fed’s aggressive rate hikes, and rising odds of a recession. More trouble awaits her hedge fund, concentrated in tech, as September job gains almost affirm another aggressive rate hike in the Fed’s next meeting.…

StockNews.com · Oct 12, 2022

Cathie Wood Is Loading up on These 5 Stocks -- Should You?

Cathie Wood’s ETFs have hit a rough patch this year amid volatile market conditions caused by sky-high inflation and the Fed’s hawkish tilt. Moreover, the stock market is expected to remain under pressure in the coming months since the central bank intends to keep hiking rates. So, we think it…

StockNews.com · Sep 27, 2022

Read news from The Economist, FT, and more,
with one subscription

1 Stock to Buy This Week and 1 Stock to Dump

Investors’ sentiment is significantly mixed at the moment, with market volatility at its peak. It could be wise to buy quality stock Vertex Pharmaceuticals (VRTX), which possesses robust financials. However, fundamentally weak stock NeoGenomics (NEO) is best avoided now. Read on….

StockNews.com · Aug 1, 2022

Coverage From

People

Cathie Wood

715 stories

Mangeet Kaur BounsMangeet

595 stories

Santanu RoyHaving

215 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Bed Bath & Beyond Inc

44 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.